ACRYLAMIDE

Acrylamide
Calleman CJ, Wu Y, He F, Tian G, Bergmark E, Zhang S, Deng H, Wang Y, Crofton KM,
Fennell T, et al., 1994.
Relationships between biomarkers of exposure and neurological effects in a group of
workers exposed to acrylamide.
Toxicol Appl Pharmacol, 126(2):361-71.
Collins JJ, 1984.
A proportional mortality ratio analysis of workers exposed to acrylamide at the warners
plant.
Epidemiology Section, American Cyanamid Company.
Collins JJ, Swaen GMH, Marsh GM, Utidjian HMD, Caporossi JC, Lucas LJ, 1989.
Mortality patterns among workers exposed to acrylamide.
J. Occup. Med., 31(7):614-617.
Dearfield KL, Abernathy CO, Ottley MS, Brantner JH, Hayes PF, 1988.
Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and
carcinogenicity.
Mutation Research, 195:45-77.
Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ, 1995.
Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk.
Mutation Research, 330:71-99.
Dobrzy_ska MM, Gajewski AK, 2000.
Induction of micronuclei in bone marrow and sperm head abnormalities after combined
exposure of mic to low doses of X-rays and acrylamide.
Terat., Carcinog., Mutag., 20:133-140.
Dooms-Goossens, Garmyn M, Degreef H, 1991.
Contact allergy to acrylamide.
Contact Dermatitis, 24:71-72.
European Commission, 2002.
Opinion of the Scientific Committee on Food on new finding regarding the presence of
acrylamide in food.
SCF/CS/CNTM/CONT/4 final.
FAO/WHO, 2002.
Food safety consultations. Health implications of acrylamide in food. Report of a joint
FAO/WHO consultation.
WHO, Geneva, Switzerland, 25-27 June 2002.
Gutierrez-Espeleta GA, Hughes LA, Piegorsch WW, Shelby MD, Generoso WM, 1992.
Acrylamide: Dermal exposure produces genetic damage in male mouse germ cells.
Fundam. Appl. Toxicol., 18:189-192.
Hagmar L, Törnqvist M, Nordander C, Rosén I, Bruze M, Kautiainen A, Magnusson AL,
Malmberg B, Aprea P, Granath F, Axmon A.
Health effects of occupational exposure to acrylamide using hemoglobin adducts as
biomarkers of internal dose.
Scand. J. Work Environ. Health, 27(4):219-226.
Hashimoto K, Sakamoto J, Tanii H, 1981.
13